ArticleJournal of clinical medicine2022

Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia.

Shun Kohsaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.